Targeting Mucin Protein Enables Rapid and Efficient Ovarian Cancer Cell Capture: Role of Nanoparticle Properties in Efficient Capture and Culture
Small · 2023
DOI: 10.1002/smll.202207154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Nathan Feely und 6 weiteren Autor:innen. Beteiligte Einrichtung: Conway Institute for Biomedical Research and School of Chemistry, University College Dublin, 61 Adair, Sandymount Ave, Dublin, CO. DUBLIN, 00004, Ire…. Hauptthemen laut MEDLINE: Nanoparticles, Ovarian Neoplasms, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland.
Abstract (Originalsprache)
The development of specific and sensitive immunomagnetic cell separation nanotechnologies is central to enhancing the diagnostic relevance of circulating tumor cells (CTCs) and improving cancer patient outcomes. The limited number of specific biomarkers used to enrich a phenotypically diverse set of CTCs from liquid biopsies has limited CTC yields and purity. The ultra‐high molecular weight mucin, mucin16 (MUC16) is shown to physically shield key membrane proteins responsible for activating immune responses against ovarian cancer cells and may interfere with the binding of magnetic nanoparticles to popular immunomagnetic cell capture antigens. MUC16 is expressed in ≈90% of ovarian cancers and is almost universal in High Grade Serous Epithelial Ovarian Cancer. This work demonstrates that cell bound MUC16 is an effective target for rapid immunomagnetic extraction of expressor cells with near quantitative yield, high purity and viability from serum. The results provide a mechanistic insight into the effects of nanoparticle physical properties and immunomagnetic labeling on the efficiency of immunomagnetic cell isolation. The growth of these cells has also been studied after separation, demonstrating that nanoparticle size impacts cell‐particle behavior and growth rate. These results present the successful isolation of “masked” CTCs enabling new strategies for the detection of cancer recurrence and select and monitor chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Conway Institute for Biomedical Research and School of Chemistry, University College Dublin, 61 Adair, Sandymount Ave, Dublin, CO. DUBLIN, 00004, Ireland.
- Magnostics Ltd, 2 Clifton Lane, Merrion Road, Monkstown, Dublin, A94 A306, Ireland.
- École nationale supérieure des ingénieurs en arts chimiques et technologiques, Toulouse, 31030, France.
ORCID-Profile: Gil U Lee
Förderung
- Science Foundation Ireland
Zitieren
APA
Feely, N., Wdowicz, A., Chevalier, A., Wang, Y., Li, P., Rollo, F., & Lee, G. U. (2023). Targeting Mucin Protein Enables Rapid and Efficient Ovarian Cancer Cell Capture: Role of Nanoparticle Properties in Efficient Capture and Culture. Small. https://doi.org/10.1002/smll.202207154
Vancouver
Feely N, Wdowicz A, Chevalier A, Wang Y, Li P, Rollo F, et al. Targeting Mucin Protein Enables Rapid and Efficient Ovarian Cancer Cell Capture: Role of Nanoparticle Properties in Efficient Capture and Culture. Small. 2023. doi:10.1002/smll.202207154
BibTeX
@article{Feely2023,
author = {Feely, Nathan and Wdowicz, Anita and Chevalier, Anne and Wang, Ying and Li, Peng and Rollo, Fanny and Lee, Gil U},
title = {Targeting Mucin Protein Enables Rapid and Efficient Ovarian Cancer Cell Capture: Role of Nanoparticle Properties in Efficient Capture and Culture},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202207154}
}
EUVIMED